Published in Circulation on November 09, 1999
Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A (2004) 4.13
Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc Natl Acad Sci U S A (2009) 2.51
A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. Tissue Eng Part A (2012) 1.95
Targeted myocardial microinjections of a biocomposite material reduces infarct expansion in pigs. Ann Thorac Surg (2008) 1.82
Cardiac tissue engineering using perfusion bioreactor systems. Nat Protoc (2008) 1.65
Scaffold-free human cardiac tissue patch created from embryonic stem cells. Tissue Eng Part A (2009) 1.42
Fabrication of functional three-dimensional tissues by stacking cell sheets in vitro. Nat Protoc (2012) 1.37
Biomimetic approach to cardiac tissue engineering. Philos Trans R Soc Lond B Biol Sci (2007) 1.31
Induced regeneration--the progress and promise of direct reprogramming for heart repair. Nat Med (2013) 1.17
Biomaterial strategies for alleviation of myocardial infarction. J R Soc Interface (2011) 1.13
Cardiac tissue engineering for replacement therapy. Heart Fail Rev (2003) 1.09
Fibroblast sheets co-cultured with endothelial progenitor cells improve cardiac function of infarcted hearts. J Artif Organs (2008) 1.06
Patching the heart: cardiac repair from within and outside. Circ Res (2013) 1.04
Perfusion seeding of channeled elastomeric scaffolds with myocytes and endothelial cells for cardiac tissue engineering. Biotechnol Prog (2010) 0.98
PGS:Gelatin nanofibrous scaffolds with tunable mechanical and structural properties for engineering cardiac tissues. Biomaterials (2013) 0.98
Stem cells for heart cell therapies. Tissue Eng Part B Rev (2008) 0.98
Cardiac tissue engineering using stem cells. IEEE Eng Med Biol Mag (2009) 0.97
A modular approach to cardiac tissue engineering. Tissue Eng Part A (2010) 0.96
The significance of pore microarchitecture in a multi-layered elastomeric scaffold for contractile cardiac muscle constructs. Biomaterials (2010) 0.95
Reconstitution of the Frank-Starling mechanism in engineered heart tissues. Biophys J (2006) 0.94
Engineered fetal cardiac graft preserves its cardiomyocyte proliferation within postinfarcted myocardium and sustains cardiac function. Tissue Eng Part A (2011) 0.94
Heart regeneration with engineered myocardial tissue. Annu Rev Biomed Eng (2014) 0.93
Regenerating functional heart tissue for myocardial repair. Cell Mol Life Sci (2012) 0.92
Concise review: cell therapy and tissue engineering for cardiovascular disease. Stem Cells Transl Med (2012) 0.90
Transplantation of mesenchymal stem cells within a poly(lactide-co-epsilon-caprolactone) scaffold improves cardiac function in a rat myocardial infarction model. Eur J Heart Fail (2009) 0.89
Control of crosslinking for tailoring collagen-based scaffolds stability and mechanics. Acta Biomater (2015) 0.87
Cardiac tissue engineering: implications for pediatric heart surgery. Pediatr Cardiol (2009) 0.86
Bioartificial heart: a human-sized porcine model--the way ahead. PLoS One (2014) 0.84
Transplantation of engineered cardiac muscle flaps in syngeneic rats. Tissue Eng Part A (2012) 0.84
Regenerative therapies using cell sheet-based tissue engineering for cardiac disease. Cardiol Res Pract (2011) 0.84
Pluripotent stem cells for cardiac regeneration: overview of recent advances & emerging trends. Indian J Med Res (2013) 0.82
Engineered myocardial tissues constructed in vivo using cardiomyocyte-like cells derived from bone marrow mesenchymal stem cells in rats. J Biomed Sci (2012) 0.82
Strategies for tissue engineering cardiac constructs to affect functional repair following myocardial infarction. J Cardiovasc Transl Res (2011) 0.82
Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review. J R Soc Interface (2015) 0.82
Concise review: Engineering myocardial tissue: the convergence of stem cells biology and tissue engineering technology. Stem Cells (2013) 0.81
Lost in translation: what is limiting cardiomyoplasty and can tissue engineering help? Curr Stem Cell Res Ther (2009) 0.79
Physiologically inspired cardiac scaffolds for tailored in vivo function and heart regeneration. Biomed Mater (2015) 0.79
Regenerative therapy and tissue engineering for the treatment of end-stage cardiac failure: new developments and challenges. Biomatter (2013) 0.78
Cardiac tissue engineering and regeneration using cell-based therapy. Stem Cells Cloning (2015) 0.78
Advances in cell transplantation therapy for diseased myocardium. Stem Cells Int (2011) 0.78
Optimisation of UV irradiation as a binding site conserving method for crosslinking collagen-based scaffolds. J Mater Sci Mater Med (2015) 0.78
Progenitor/stem cell transplantation for repair of myocardial infarction: Hype or hope? Ann Palliat Med (2012) 0.77
Gene expression profiles in engineered cardiac tissues respond to mechanical loading and inhibition of tyrosine kinases. Physiol Rep (2013) 0.77
Minimally invasive cell-seeded biomaterial systems for injectable/epicardial implantation in ischemic heart disease. Int J Nanomedicine (2012) 0.77
Electrical and Mechanical Strategies to Enable Cardiac Repair and Regeneration. IEEE Rev Biomed Eng (2015) 0.77
Cell and gene therapy approaches for cardiac vascularization. Cells (2012) 0.76
Engineered Tissue Patch for Cardiac Cell Therapy. Curr Treat Options Cardiovasc Med (2015) 0.76
Striated muscle function, regeneration, and repair. Cell Mol Life Sci (2016) 0.76
In vivo experience with natural scaffolds for myocardial infarction: the times they are a-changin'. Stem Cell Res Ther (2015) 0.76
Tissue Engineering Strategies for Myocardial Regeneration: Acellular Versus Cellular Scaffolds? Tissue Eng Part B Rev (2016) 0.75
Bioacoustic-enabled patterning of human iPSC-derived cardiomyocytes into 3D cardiac tissue. Biomaterials (2017) 0.75
Regeneration of a heart cell. Yale J Biol Med (2009) 0.75
Autologous Skeletal Myoblast Sheet Therapy for Porcine Myocardial Infarction Without Increasing Risk of Arrhythmia. Cell Med (2013) 0.75
Implantation of a Poly-L-Lactide GCSF-Functionalized Scaffold in a Model of Chronic Myocardial Infarction. J Cardiovasc Transl Res (2017) 0.75
Autologous transplantation of bone marrow cells improves damaged heart function. Circulation (1999) 3.17
Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg (2002) 2.88
Angiogenesis by endothelial cell transplantation. J Thorac Cardiovasc Surg (2001) 2.12
Deep sternal wound infection: risk factors and outcomes. Ann Thorac Surg (1998) 1.82
Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy. Circulation (1997) 1.69
Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American Association for Thoracic Surgery, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Ann Thorac Surg (1996) 1.67
Neuropsychologic impairment after coronary bypass surgery: effect of gaseous microemboli during perfusionist interventions. J Thorac Cardiovasc Surg (2001) 1.64
Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol (1996) 1.58
Cerebral microemboli during cardiopulmonary bypass: increased emboli during perfusionist interventions. Ann Thorac Surg (1999) 1.54
Guidelines for reporting morbidity and mortality after cardiac valvular operations. Eur J Cardiothorac Surg (1988) 1.50
The cell type-specific expression of the murine IL-13 gene is regulated by GATA-3. J Immunol (2001) 1.47
Autologous smooth muscle cell transplantation improved heart function in dilated cardiomyopathy. Ann Thorac Surg (2000) 1.47
ROG, repressor of GATA, regulates the expression of cytokine genes. Immunity (2000) 1.46
Insulin cardioplegia for elective coronary bypass surgery. J Thorac Cardiovasc Surg (2000) 1.44
Results of represervation of the chordae tendineae during redo mitral valve replacement. Ann Thorac Surg (1996) 1.41
Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of The American Association for Thoracic Surgery and The Society of Thoracic Surgeons. J Thorac Cardiovasc Surg (1996) 1.41
Predictors of low cardiac output syndrome after coronary artery bypass. J Thorac Cardiovasc Surg (1996) 1.40
Risk factors for late pulmonary homograft stenosis after the Ross procedure. Ann Thorac Surg (2000) 1.39
Myocardial perfusion during warm antegrade and retrograde cardioplegia: a contrast echo study. Ann Thorac Surg (1999) 1.39
Main neurodevelopmental study of Seychellois children following in utero exposure to methylmercury from a maternal fish diet: outcome at six months. Neurotoxicology (1995) 1.37
Consequences of postoperative alterations in respiratory mechanics. Am J Surg (1974) 1.34
Fifteen-year trends in risk severity and operative mortality in elderly patients undergoing coronary artery bypass graft surgery. Circulation (1998) 1.32
Results of combined pulmonary resection and cardiac operation. Ann Thorac Surg (1996) 1.24
Technique of successful clinical double-lung transplantation. Ann Thorac Surg (1988) 1.23
The Seychelles child development study on neurodevelopmental outcomes in children following in utero exposure to methylmercury from a maternal fish diet: background and demographics. Neurotoxicology (1995) 1.22
Cardiomyocyte transplantation improves heart function. Ann Thorac Surg (1996) 1.20
Smooth muscle cell transplantation into myocardial scar tissue improves heart function. J Mol Cell Cardiol (1999) 1.19
Metabolic and structural changes in skeletal muscle during hypocaloric dieting. Am J Clin Nutr (1984) 1.18
Effects of prenatal methylmercury exposure from a high fish diet on developmental milestones in the Seychelles Child Development Study. Neurotoxicology (1997) 1.17
Bacterial plasmolysis as a physical indicator of viability. Appl Environ Microbiol (1996) 1.15
Future directions of vitamin E and its analogues in minimizing myocardial ischemia-reperfusion injury. Can J Cardiol (1993) 1.14
Myocardial depression during sepsis. Am J Surg (1977) 1.13
Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Ann Thorac Surg (2001) 1.13
Current concepts measurement of cardiac output by thermodilution. N Engl J Med (1975) 1.10
Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation (1997) 1.10
The efficacy of the Cox/maze procedure combined with mitral valve surgery: a matched control study. Eur J Cardiothorac Surg (2001) 1.10
Metabolic response of skeletal muscle to ischemia. Am J Physiol (1986) 1.10
A pilot neurodevelopmental study of Seychellois children following in utero exposure to methylmercury from a maternal fish diet. Neurotoxicology (1995) 1.09
The changing pattern of reoperative coronary surgery: trends in 1230 consecutive reoperations. J Thorac Cardiovasc Surg (2000) 1.08
Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles. Gene Ther (2007) 1.08
Construction of a bioengineered cardiac graft. J Thorac Cardiovasc Surg (2000) 1.08
Cell transplantation comes of age. J Thorac Cardiovasc Surg (2001) 1.07
Neurodevelopmental outcomes of Seychellois children sixty-six months after in utero exposure to methylmercury from a maternal fish diet: pilot study. Neurotoxicology (1995) 1.05
Adenosine myocardial protection: preliminary results of a phase II clinical trial. Ann Surg (1999) 1.03
The fate of a tissue-engineered cardiac graft in the right ventricular outflow tract of the rat. J Thorac Cardiovasc Surg (2001) 1.03
Identification of oxygen responsive elements in the 5'-flanking region of the human glutathione peroxidase gene. J Biol Chem (1993) 1.03
Assessment of myocardial performance and optimal volume loading during elective abdominal aortic aneurysm resection. Arch Surg (1977) 1.03
Coronary artery bypass grafting in patients with poor ventricular function. Cardiovascular Surgeons of the University of Toronto. J Thorac Cardiovasc Surg (1992) 1.02
Late hemodynamic effects of the preserved papillary muscles during mitral valve replacement. Circulation (1994) 1.01
Reoperative coronary bypass surgery: effect of patent grafts and retrograde cardioplegia. J Thorac Cardiovasc Surg (2001) 1.01
Intraoperative myocardial protection: current trends and future perspectives. Ann Thorac Surg (1999) 1.01
Community support of patients with a left ventricular assist device: The Toronto General Hospital experience. Can J Cardiol (2009) 1.01
Defining T-cell-mediated immune responses in rotavirus-infected juvenile rhesus macaques. J Virol (2004) 1.00
A comparison of the late patency rates of axillobilateral femoral and axillounilateral femoral grafts. Surgery (1977) 1.00
Right ventricular dysfunction following cold potassium cardioplegia. J Thorac Cardiovasc Surg (1985) 1.00
Adverse effects of transfusion therapy during abdominal aortic aneurysectomy. Surgery (1978) 0.99
Increased risk of urgent revascularization. J Thorac Cardiovasc Surg (1987) 0.99
Ascending aorta to bifemoral bypass--a ventral aorta. J Vasc Surg (1986) 0.99
Autologous porcine heart cell transplantation improved heart function after a myocardial infarction. J Thorac Cardiovasc Surg (2000) 0.99
Lactate release during reperfusion predicts low cardiac output syndrome after coronary bypass surgery. Ann Thorac Surg (2001) 0.98
Predictors of operative risk for coronary bypass operations in patients with left ventricular dysfunction. J Thorac Cardiovasc Surg (1999) 0.98
Sepsis presenting as acute respiratory insufficiency. Surg Gynecol Obstet (1974) 0.97
Autologous heart cell transplantation improves cardiac function after myocardial injury. Ann Thorac Surg (1999) 0.97
Guidelines for reporting morbidity and mortality after cardiac valvular operations. J Thorac Cardiovasc Surg (1988) 0.97
Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia. J Thorac Cardiovasc Surg (1986) 0.97
Association between prenatal exposure to methylmercury and developmental outcomes in Seychellois children: effect modification by social and environmental factors. Neurotoxicology (1999) 0.97